We are live on ! Find out more
GLS.WS

Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
GLS.WS

Delisted

GLS.WS was delisted on the 3rd of January, 2023.

Back to rankings

0 hedge funds and large institutions have $0 invested in Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 in 2023 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 4 → 0 (-4)

100% less capital invested

Capital invested by funds: $1.79K → $0 (-$1.79K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 4

Holders
–
Holders Change
-4
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
RCM
Radcliffe Capital Management
Pennsylvania
-$905
2
CF
Cantor Fitzgerald
New York
-$609
3
FIG
Fortress Investment Group
New York
-$278
Name Holding Trade Value Shares
Change 		Change in
Stake
CF
1
Cantor Fitzgerald
New York
– -$609 -243,446 Closed
FIG
2
Fortress Investment Group
New York
– -$278 -111,542 Closed
RCM
3
Radcliffe Capital Management
Pennsylvania
– -$905 -100,000 Closed

GLS.WS Hedge Fund Activity: Q2 2023 in Review

0 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 (GLS.WS) for Q2 2023, worth a combined $0 — down 100% from $1.79K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of GLS.WS and 0 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Radcliffe Capital Management, exiting entirely with an estimated $905 sold.

  • 0 institutional investors held Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 (GLS.WS) as of Q2 2023, down from 4 in Q1 2023.
  • Funds reported $0 of Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 stock for Q2 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 positions in Q2 2023 and 4 closed out, a net change of -4 holders.
  • The largest Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 seller in Q2 2023 was Radcliffe Capital Management, an estimated $905 sold.

Based on aggregated 13F filings for Q2 2023.